Sutee Yoksan Selected Research

Japanese Encephalitis

12/2022	Antibody persistence upto 5 years after primary immunization and booster with an inactivated chromatographically purified Vero cell-derived Japanese encephalitis vaccine in Thai children.
7/2021	Feasibility of chitosan-based nanoparticles approach for intranasal immunisation of live attenuated Japanese encephalitis vaccine.
1/2021	Immunogenicity of Vero Cell Culture-derived Japanese Encephalitis Vaccine in Pediatric and Young Hematopoietic Stem Cell Transplantation Recipients.
1/2020	Immunogenicity and safety of two-visit, intradermal pre-exposure rabies prophylaxis simultaneously administrated with chimeric live-attenuated Japanese encephalitis vaccine in children living in rabies and Japanese encephalitis endemic country.
1/2019	Low population Japanese encephalitis virus (JEV) seroprevalence in Udayapur district, Nepal, three years after a JE vaccination programme: A case for further catch up campaigns?
1/2017	Persistence of Wild-Type Japanese Encephalitis Virus Strains Cross-Neutralization 5 Years After JE-CV Immunization.
11/2016	Immunogenicity of live attenuated Japanese encephalitis SA 14-14-2 vaccine among Sri Lankan children with previous receipt of inactivated JE vaccine.
10/2016	Immunogenicity of a Japanese encephalitis chimeric virus vaccine as a booster dose after primary vaccination with SA14-14-2 vaccine in Thai children.
2/2016	Immunological evidence of Zika virus transmission in Thailand.
8/2014	Safety and immunogenicity of live-attenuated Japanese encephalitis SA 14-14-2 vaccine co-administered with measles vaccine in 9-month-old infants in Sri Lanka.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sutee Yoksan Research Topics

Disease

37	Dengue (Dengue Fever) 01/2021 - 01/2002
31	Infections 12/2022 - 09/2004
23	Japanese Encephalitis 12/2022 - 01/2002
7	Severe Dengue 10/2019 - 05/2005
5	Fever (Fevers) 01/2020 - 01/2008
4	Viremia 10/2013 - 01/2002
3	Yellow Fever 03/2006 - 01/2002
2	Measles 08/2014 - 04/2008
1	Vaccine-Preventable Diseases 01/2021
1	Smallpox (Variola) 07/2020
1	Poliomyelitis (Polio) 07/2020
1	Virus Diseases (Viral Diseases) 01/2020
1	Rabies (Hydrophobia) 01/2020
1	Chikungunya Fever 02/2015
1	Coinfection 07/2014
1	Necrosis 05/2013
1	Anemia 03/2012
1	Hemorrhage 03/2012
1	Arbovirus Infections 02/2010
1	Flavivirus Infections 01/2002

Drug/Important Bio-Agent (IBA)

30	VaccinesIBA 12/2022 - 01/2002
11	Neutralizing AntibodiesIBA 01/2021 - 03/2002
10	AntibodiesIBA 12/2014 - 09/2003
8	Immunoglobulin G (IgG)IBA 01/2021 - 09/2003
8	Proteins (Proteins, Gene)FDA Link 07/2020 - 01/2002
8	Dengue VaccinesIBA 10/2019 - 09/2003
7	AntigensIBA 02/2016 - 10/2003
6	Immunoglobulin M (IgM)IBA 01/2021 - 12/2009
6	EnzymesIBA 10/2019 - 10/2006
4	ImmunosorbentsIBA 10/2019 - 10/2006
4	Attenuated VaccinesIBA 10/2015 - 01/2002
3	CytokinesIBA 01/2015 - 12/2012
2	Viral RNAIBA 01/2021 - 09/2006
2	Orlistat (Xenical)FDA Link 01/2020 - 01/2017
2	Monoclonal AntibodiesIBA 10/2019 - 02/2015
2	Antiviral Agents (Antivirals)IBA 12/2015 - 12/2010
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2015 - 12/2014
2	Viral AntigensIBA 01/2015 - 12/2009
2	Measles VaccineIBA 08/2014 - 04/2008
2	Biological ProductsIBA 07/2014 - 02/2010
2	ChimeriVaxIBA 10/2003 - 01/2002
1	PolymersIBA 07/2021
1	maleimideIBA 07/2021
1	ChitosanIBA 07/2021
1	Edetic Acid (EDTA)FDA Link 01/2020
1	Rabies Vaccines (Rabies Vaccine)FDA Link 01/2020
1	Japanese Encephalitis VaccinesIBA 01/2020
1	Small Interfering RNA (siRNA)IBA 01/2017
1	LipidsIBA 01/2017
1	Fatty Acid Synthases (Fatty Acid Synthase)IBA 01/2017
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2017
1	EpitopesIBA 01/2016
1	InterferonsIBA 12/2015
1	InterleukinsIBA 01/2015
1	Caspase 8 (Caspase-8)IBA 12/2014
1	ChemokinesIBA 12/2012
1	isothiocyanic acidIBA 12/2009
1	Fluorescein (Funduscein)FDA LinkGeneric 12/2009
1	Viral ProteinsIBA 01/2009
1	ThrombomodulinIBA 10/2006
1	Broadly Neutralizing AntibodiesIBA 03/2006
1	Intercellular Adhesion Molecule-3IBA 05/2005
1	P-2 (P 2)IBA 05/2005

Therapy/Procedure

1	Hematopoietic Stem Cell Transplantation 01/2021
1	Drug Therapy (Chemotherapy) 03/2012
1	Highly Active Antiretroviral Therapy (HAART) 11/2007